share_log

Ayala Pharmaceuticals | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-I.B.F Management Ltd.(83.6%),Israel Biotech Fund II, L.P.(71.0%), etc.

Ayala Pharmaceuticals | SC 13D/A:超过5%持股股东披露文件(修正)-I.B.F Management Ltd.(83.6%),Israel Biotech Fund II, L.P.(71.0%)等

美股SEC公告 ·  2023/11/21 22:00
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息